Shares of Datavault AI (DVLT) slid 7.3% to $0.15 on September 23 after the company unveiled a massive rights offering that could raise up to $125 million — a figure that dwarfs the company's own market value. The announcement landed at 8:03 a.m. EDT , just before trading opened, giving investors little time to digest terms that layer new common shares, preferred stock, and additional purchase rights on top of an already-ballooning share count.
The Offering Price Signals Management Thinks the Stock Is Worth More — But the Market Disagrees. Each Common Unit costs $0.20 and includes one share plus two rights to buy additional shares at $0.25 and $0.30, expiring six and twelve months from closing. With DVLT trading at $0.15, the $0.20 subscription price sits above the market price, meaning investors would overpay unless they believe the stock rebounds. The deal also includes up to 3 million Preferred Units worth $75 million, carrying a $25 liquidation preference and a cumulative $2.10-per-share annual dividend. That preferred layer ranks ahead of common stockholders in a liquidation — an added risk for ordinary shareholders.
A Share Count Already Up 1,500% in a Year Could Explode Further. DVLT currently has roughly 856 million shares outstanding, a count that has surged 1,518% over the past year.
Up to $50 million of common unit rights alone could mint hundreds of millions of additional shares at $0.20, severely diluting existing holders if exercised.
Lawsuits and Credibility Questions Complicate the Capital Raise. Multiple law firms have filed securities fraud class actions alleging Datavault made "materially false and misleading statements" about its business during a class period running from September 2024 through October 2025.
The complaints allege the company overstated platform trading activity, which "was in fact minimal." With an October 5, 2026 lead-plaintiff deadline, legal risk hangs directly over the subscription period.
The Revenue Gap Remains Enormous. Over the past twelve months DVLT generated just $41.9 million in revenue against $122.6 million in net losses.
Management has reaffirmed a $200 million full-year 2026 revenue target , but achieving nearly five times trailing revenue in one year — while defending fraud suits and digesting a dilutive capital raise — strains credulity. The rights offering may keep the lights on, but at $0.15 a share, existing investors are paying for survival, not growth.